Key facts
- This page summarizes Denise Zamore's Form 4 filing for agilon health, inc. (AGL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Apr 2025, 19:39.
Denise Zamore - 01 Apr 2025 Form 4 Insider Report for agilon health, inc. (AGL)
- Reporting relationship
- Chief Legal Officer
- Issuer ticker
- AGL
- Reported as of
- 01 Apr 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Apr 2025, 19:39:33 UTC
- Prior SEC filing
- 24 Mar 2025
- Next SEC filing
- 16 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mimi Yang, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Denise Zamore filed Form 4 for agilon health, inc. (AGL) on 03 Apr 2025.
Change
- Previous filing in this sequence was filed on 24 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AGL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +245,099
- Change %
- +120%
- Price
- $0.000000
- Shares after
- 450,047
- Date
- 01 Apr 2025
- Ownership
- Direct
- Footnotes
- F1, F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AGL
transaction
Derivative
Options (Right to buy)
Award
- Transaction value
- $0
- Shares
- +384,616
- Change %
- Price
- $0.000000
- Shares after
- 384,616
- Date
- 01 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 384,616
- Exercise price
- $4.08
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Restricted stock units that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment.
Footnote F2
Includes Performance Stock Units which may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date.
Footnote F3
Includes restricted stock units.
Footnote F4
Options that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment.